Clinical Trial Update: Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on reactogenicity and immunogenicity after measles-rubella routine immunization in Indonesian infants and children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunization Related Safety Issues
• Measles
• Rubella

Drugs mentioned

• Measles-Rubella Vaccine (Measles and Rubella vaccine)

Snippet

Sponsor: PT Bio Farma | Conditions: Safety Issues, Immunogenicity | Phase 4 | Status: COMPLETED